Tandem Diabetes Care (TNDM) Non-Current Deffered Revenue (2013 - 2026)

Tandem Diabetes Care (TNDM) has reported Non-Current Deffered Revenue for 12 consecutive years, with $7.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-Current Deffered Revenue fell 18.79% year-over-year to $7.8 million; the trailing twelve-month figure through Jun 2026 stood at $7.8 million (down 18.79% YoY), and the FY2025 full-year result was $8.5 million, down 18.95% from the prior year.
• Non-Current Deffered Revenue eased to $7.8 million in Q2 2026 per TNDM's latest filing, from $8.0 million in the prior quarter.
• Across five years, Non-Current Deffered Revenue topped out at $19.1 million in Q3 2022 and bottomed at $7.8 million in Q2 2026.
• Historically, Non-Current Deffered Revenue has averaged $12.7 million across 5 years, with a median of $12.0 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Non-Current Deffered Revenue declined 0.39% in 2022, then declined 26.4% in 2023.
• Over 5 years, Non-Current Deffered Revenue stood at $16.9 million in 2022, then slipped by 21.0% to $13.3 million in 2023, then retreated by 21.57% to $10.5 million in 2024, then dropped by 18.95% to $8.5 million in 2025, then decreased by 8.24% to $7.8 million in 2026.
• According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $7.8 million, $8.0 million, and $8.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.